LDL Goals for Diabetic Patients

Primary LDL Goals Based on Risk Stratification

The American Diabetes Association recommends an LDL cholesterol goal of <100 mg/dL for diabetic patients without overt cardiovascular disease, while a more aggressive goal of <70 mg/dL is recommended for those with established cardiovascular disease or multiple risk factors 1, 2
For diabetic patients with overt cardiovascular disease, the LDL-C goal is <70 mg/dL, as recommended by the American College of Cardiology and the European Heart Society 1, 2
Diabetic patients with multiple cardiovascular risk factors should consider an optional LDL-C goal of <70 mg/dL, according to the Journal of the American College of Cardiology and Circulation 4, 5

Established cardiovascular disease is a risk factor that defines "very high risk" status, as stated by the American Diabetes Association and the European Heart Journal 1, 2
Multiple major risk factors, especially poorly controlled risk factors, contribute to "very high risk" status, as noted by Circulation 5
Severe and poorly controlled risk factors, such as continued cigarette smoking, are associated with "very high risk" status, according to the Journal of the American College of Cardiology 4
Multiple risk factors of metabolic syndrome, including triglycerides ≥200 mg/dL and non-HDL-C ≥130 mg/dL with low HDL-C, define "very high risk" status, as stated by the Journal of the American College of Cardiology 4

The American Diabetes Association recommends lifestyle modification as first-line therapy, focusing on reduction of saturated fat, trans fat, and cholesterol intake, as well as weight loss and increased physical activity 1, 3
Statin therapy should be added to lifestyle therapy for diabetic patients with overt CVD or those over age 40 with one or more CVD risk factors, as recommended by the American Diabetes Association 1
The intensity of therapy should be sufficient to achieve at least a 30-40% reduction in LDL-C levels, according to Circulation and Arteriosclerosis, Thrombosis, and Vascular Biology 5, 6

The American Diabetes Association recommends measuring fasting lipid profile at least annually in most adult diabetic patients 1, 3
In adults with low-risk lipid values, lipid assessments may be repeated every 2 years, as stated by the American Diabetes Association 1

When calculating LDL-C in patients with very low levels or elevated triglycerides, direct measurement methods may be more accurate than the standard Friedewald equation, according to the European Heart Journal 7

Clinical trials have demonstrated significant reductions in cardiovascular events and mortality with statin therapy in diabetic patients, as noted by the American Diabetes Association and Diabetes Care 1, 3
Evidence suggests that additional benefit may be obtained by reducing LDL-C to substantially below 100 mg/dL, with no apparent threshold below which no further benefit is achieved, according to the Journal of the American College of Cardiology and Circulation 4, 5
The TNT study showed that intensive lipid-lowering therapy reaching a mean LDL-C level of 77 mg/dL provided significant clinical benefit beyond that of less intensive therapy, as reported by the American Journal of Kidney Diseases 8